MyOwnMed is pleased to announce an exciting evolution in its mission to improve and accelerate the delivery of
life-changing medicines to patients in need. Following the acquisition and integration of Santé Value, MyOwnMed will now operate as RespondHealth.

 

Built in partnership with Microsoft Azure, the AI-driven RESPOND platform is built to radically change the way research and clinical trials are designed and executed, surfacing the real-world measures that matter – in real time.

 

Applications are limitless – spanning novel medicines, diagnostic products and healthcare for all.